<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03259282</url>
  </required_header>
  <id_info>
    <org_study_id>35RC16_3046_GAMES</org_study_id>
    <nct_id>NCT03259282</nct_id>
  </id_info>
  <brief_title>Gammaglobulins Level is Predictive Factor of Evolution in Sarcoidosis</brief_title>
  <acronym>GAMES</acronym>
  <official_title>Gammaglobulins Level is Predictive Factor of Evolution in Sarcoidosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rennes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of the rate of achievement of serum protein electrophoresis (PPE) in diagnosis in
      a retrospective cohort of patients at Rennes University Hospital
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In 50% of cases, sarcoidosis is associated with polyclonal hypergammaglobulinemia. The other
      forms have a normal gamma globulin level.

      The level of gamma globulinemia has not yet been studied as an evolutionary predictive
      factor. Furthermore, there are disseminated granulomatoses sharing common characteristics
      with sarcoidosis, associated with Common Variable Immunodeficiency deficit (DICV) type
      Primary Immunodeficiency syndrome (DIP), thus occurring in hypogammaglobulinemic patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 7, 2017</start_date>
  <completion_date type="Actual">March 22, 2017</completion_date>
  <primary_completion_date type="Actual">March 22, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Study of gamma globulin level present in the blood at the time of diagnosis of sarcoidosis on disease activity</measure>
    <time_frame>Day 1</time_frame>
    <description>Electrophoresis rates of serum proteins</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Study of gamma globulin level present in the blood at the time of diagnosis of sarcoidosis on the course of the disease</measure>
    <time_frame>Day 1</time_frame>
    <description>Electrophoresis rates of serum proteins</description>
  </primary_outcome>
  <enrollment type="Actual">78</enrollment>
  <condition>Sarcoidosis</condition>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Analysis of gamma globulin</intervention_name>
    <description>Electrophoresis of proteins</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with sarcoidosis
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Patients newly diagnosed with sarcoidosis

        Exclusion Criteria:

          -  Comorbidity responsible for a change in the level of gamma globulin

          -  Other etiology of granulomatosis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHU de Rennes</name>
      <address>
        <city>Rennes</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 21, 2017</study_first_submitted>
  <study_first_submitted_qc>August 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 23, 2017</study_first_posted>
  <last_update_submitted>April 10, 2018</last_update_submitted>
  <last_update_submitted_qc>April 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcoidosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>gamma-Globulins</mesh_term>
    <mesh_term>Immunoglobulins, Intravenous</mesh_term>
    <mesh_term>Rho(D) Immune Globulin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

